Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Clinical Trials

Behind the scenes with the unsung heroes of cancer clinical trials – Part 1

We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves.

Vaccine may reduce HPV infections that cause some oral cancers

Study finds that young adults in the US who hadn’t been vaccinated were around 14 times more likely to have oral HPV infections than those who were vaccinated.

Taking a potential new breast cancer treatment from the lab to the clinic

Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.

Testing a new immunotherapy treatment for neuroblastoma

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

Keyhole surgery a ‘better approach’ for women with early stage womb cancer

Survival in women who have less invasive surgery for early-stage womb cancer is just as good as traditional surgery.

Trial to test for Barrett’s oesophagus launches in GP surgeries across the UK

A Cancer Research UK-funded trial allowing GP surgeries to test for Barrett’s oesophagus launches today.

Giving pancreatic cancer patients better opportunities to join clinical trials

We're backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.

New era in precision medicine for pancreatic cancer

New treatments for pancreatic cancer are set to be transformed by a network of clinical trials - to find the right trial for the right patient.

British Science Week: 10 of the biggest changes in cancer research over the last 20 years

This year’s British Science Week runs from 10th – 19th March, and the theme is ‘change’.

Immunotherapy drug extends lives of advanced lung cancer patients

A drug that ‘reinvigorates the immune system’ can extend the lives of lung cancer patients with reduced side effects.

Pages